Credent Connect N Care IPO: Complete Analysis, Dates, Financials & Review
Are you looking to invest in the rapidly expanding healthcare logistics sector? The Credent Connect N Care IPO is generating significant interest among market participants. Opening for subscription in mid-August 2026, this SME Initial Public Offering brings an opportunity to partake in a technology-enabled operational and supply chain enterprise.
In this comprehensive guide, we dissect every critical aspect of the Credent Connect N Care IPO. From the core business model and latest financial performance to valuation metrics and investment lot sizes, we provide a holistic overview to help you make an informed decision.
Business Overview: What Does Credent Connect N Care Do?
Originally incorporated in 2015 as Credent Cold Chain Logistics Private Limited, Credent Connect N Care Limited has evolved into a premier integrated healthcare services and logistics provider. The company predominantly operates on a Business-to-Business (B2B) framework, catering to diagnostic labs, pharmaceutical giants, hospitals, and In-Vitro Diagnostics (IVD) companies across India.
Core Operations & Services
- Healthcare Logistics: Specialized movement of diagnostic samples, reagents, and medical supplies using temperature-controlled (cold-chain) and time-sensitive transport solutions.
- Diagnostic & Paramedical Support: Supplying trained phlebotomists for home sample collections, alongside providing stationed laboratory manpower services.
- Technology-Driven Platforms: Leveraging proprietary tech platforms like "C3 Post" for courier aggregation and real-time operational tracking.
- Corporate Wellness: Operating under the brand "C3 Wellness," they conduct health camps, vaccination drives, and preventive check-ups for corporate workforces.
Operating with a robust workforce of 6,338 employees (as of March 2026) and holding ISO 9001:2015 and ISO 15189:2022 certifications, the company has heavily bolstered its market presence through strategic acquisitions like Alltrak Technologies and Credent Healthcare.
Credent Connect IPO Schedule & Timeline
Tracking the critical dates is essential for a smooth application process. The entire bidding to listing cycle is scheduled over a span of a week. Below is the progress tracking of the IPO:
Crucial IPO Issue Details
The company is aiming to raise roughly ₹94 Crores entirely through a fresh issue of shares. Here is the structured breakdown of the offering:
| Parameter | Details |
|---|---|
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| Price Band | ₹179 to ₹189 per share |
| Total Issue Size | 49,68,000 shares (Aggregating ₹93.90 Cr) |
| Fresh Issue Size | 49,68,000 shares (Ex-Market Maker: 47.16 Lakh shares) |
| Listing Exchange | NSE SME |
| Market Maker Portion | 2,52,000 shares |
Subscription Lot Size & Investor Allocation
For retail investors and High Net-worth Individuals (HNIs), the capital requirement is defined by the lot sizes. The minimum investment requires bidding for at least one lot.
Lot Size Breakdown
| Investor Category | Minimum Lots | Shares Total | Investment Required (₹) |
|---|---|---|---|
| Retail (Min & Max) | 2 Lots | 1,200 Shares | ₹2,26,800 |
| Small HNI (Min) | 3 Lots | 1,800 Shares | ₹3,40,200 |
| Small HNI (Max) | 8 Lots | 4,800 Shares | ₹9,07,200 |
| Big HNI (Min) | 9 Lots | 5,400 Shares | ₹10,20,600 |
Reservation Quota
- QIB (Qualified Institutional Buyers): 49.87% of Net Issue
- Retail Individual Investors: 35.11% of Net Issue
- NII (Non-Institutional Investors/HNI): 15.01% of Net Issue
Company Financial Performance
A deep dive into the financial statements reveals a massive operational scale-up in the most recent fiscal year. After a steady run in FY24 and FY25, the consolidated figures for FY26 show a dramatic surge in both top-line revenue and bottom-line profit.
| Financial Metric (₹ in Crores) | FY 2024 (Standalone) | FY 2025 (Standalone) | FY 2026 (Consolidated) |
|---|---|---|---|
| Total Assets | 26.41 | 29.50 | 81.57 |
| Total Revenue | 76.02 | 78.23 | 214.43 |
| Profit After Tax (PAT) | 2.66 | 2.25 | 18.45 |
| EBITDA | 4.30 | 4.99 | 28.46 |
| Net Worth | 13.66 | 15.90 | 43.79 |
| Total Borrowings | 6.85 | 7.42 | 21.95 |
Valuation Metrics & Key Performance Indicators
To understand if the IPO is fairly priced, evaluating the company’s Key Performance Indicators (KPIs) based on FY26 earnings is crucial.
| Indicator | Value (As of March 2026) |
|---|---|
| Pre-IPO EPS | ₹13.92 |
| Post-IPO EPS (Estimated) | ₹10.12 |
| P/E Ratio | 13.58x (Pre-IPO) / 18.68x (Post-IPO) |
| Return on Equity (ROE) | 61.81% |
| Return on Capital Employed (ROCE) | 40.00% |
| Debt to Equity Ratio | 0.50 |
| Market Cap at Offer Price | ₹344.41 Crores |
Objectives of the Issue & Anchor Participation
Capital raised through public markets must have clear deployable goals. Credent Connect N Care has earmarked the net proceeds (approximately ₹72.80 Crores after expenses) for the following core areas:
- Working Capital for Company: ₹37.00 Crores allocated to meet standalone operational working capital requirements.
- Subsidiary Investments: ₹26.80 Crores for working capital and ₹3.00 Crores for capital expenditure (machinery) infused into their wholly-owned subsidiary, Credent Healthcare Private Limited.
- Debt Repayment: ₹6.00 Crores designated to repay or prepay existing corporate borrowings.
- General Corporate Purposes: Balance funds utilized for strategic operational enhancements.
Anchor Investor Highlights
Before the public bidding opens, the company successfully raised ₹26.54 Crores from Anchor Investors on August 12, 2026. A total of 14,04,000 shares were allocated, signaling strong early institutional confidence.
SWOT Analysis: Credent Connect N Care
A strategic overview of the company's internal strengths and external environment:
Strengths
- Integrated end-to-end healthcare logistics platform.
- Strong technological backbone (C3 Post and C3 HRMS).
- Pan-India footprint serving high-profile B2B clients.
- Diversified revenue streams (diagnostics, wellness, manpower).
Weaknesses
- Heavy reliance on the B2B segment can lead to concentrated client risk.
- A sudden, massive spike in FY26 revenues may raise questions regarding long-term margin sustainability.
Opportunities
- Increasing demand for specialized cold-chain logistics in the pharma sector.
- Expansion scope into Tier 2 and Tier 3 cities across India.
- Scaling up the "C3 Wellness" corporate segment in a post-pandemic world.
Threats
- Highly competitive landscape with established logistics and diagnostic players.
- Strict regulatory environment concerning medical data and sample transportation.
Promoter Holding & Management
A company's leadership determines its future trajectory. Credent Connect N Care is backed by a robust promoter group comprising Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma, and Tanveen.
- Pre-Issue Promoter Holding: 87.64%
- Post-Issue Promoter Holding: 63.75%
This post-issue stake indicates that the original founders and promoters retain a commanding majority, aligning their interests with those of retail and institutional shareholders.
Market Analyst View & Final Conclusion
Market analysts note that the company operates in a high-growth niche—healthcare logistics intertwined with technology. While the top-line and bottom-line figures were relatively flat during FY24 and FY25, the phenomenal financial leap in FY26 makes the valuation appear aggressive if based solely on historical averages, but reasonably priced if the new growth momentum is sustained.
Conclusion: Investors with a higher risk appetite and a long-term investment horizon might find value in this technology-enabled logistics play. The substantial capital infusion towards working capital and subsidiary expansion is a positive indicator for future scalability. However, due diligence regarding the sustainability of the FY26 profit margins is highly recommended before parking substantial funds.
Registrar and Company Contact Information
For allotment status, refund queries, and company communications, investors can use the following details:
Lead Manager
Hem Securities Ltd.
Acts as the book running lead manager overseeing the public issue process.
Registrar to the Issue
Kfin Technologies Ltd.
Phone: 040-79615565
Email: credentconnect.ipo@kfintech.com
Company Details
Credent Connect N Care Ltd.
B-3, Second Floor, Nimri Commercial Complex,
Ashok Vihar, Phase-4, New Delhi, 110052
Phone: +91-9971777199
Email: cs@c3logistics.co.in